Electromed, Inc. (NYSE:ELMD) Shares Sold by Wilmington Savings Fund Society FSB

Wilmington Savings Fund Society FSB cut its stake in Electromed, Inc. (NYSE:ELMD) by 15.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,929 shares of the company’s stock after selling 1,600 shares during the quarter. Wilmington Savings Fund Society FSB owned about 0.11% of Electromed worth $264,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Hunter Associates Investment Management LLC increased its position in Electromed by 12.3% during the third quarter. Hunter Associates Investment Management LLC now owns 102,450 shares of the company’s stock worth $2,199,000 after purchasing an additional 11,250 shares during the last quarter. Navellier & Associates Inc. purchased a new stake in shares of Electromed in the 3rd quarter valued at approximately $368,000. Pekin Hardy Strauss Inc. increased its holdings in shares of Electromed by 9.9% during the 3rd quarter. Pekin Hardy Strauss Inc. now owns 38,185 shares of the company’s stock worth $820,000 after buying an additional 3,435 shares during the last quarter. Walleye Capital LLC purchased a new stake in shares of Electromed during the 3rd quarter valued at approximately $274,000. Finally, State Street Corp lifted its holdings in Electromed by 14.5% in the third quarter. State Street Corp now owns 22,066 shares of the company’s stock valued at $474,000 after acquiring an additional 2,800 shares during the last quarter. Hedge funds and other institutional investors own 40.82% of the company’s stock.

Insiders Place Their Bets

In other news, Director Andrew Summers sold 12,731 shares of Electromed stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $29.98, for a total value of $381,675.38. Following the completion of the sale, the director now directly owns 165,755 shares of the company’s stock, valued at approximately $4,969,334.90. The trade was a 7.13 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 14.00% of the stock is owned by insiders.

Analyst Ratings Changes

Separately, StockNews.com upgraded Electromed from a “buy” rating to a “strong-buy” rating in a research report on Tuesday.

Electromed Price Performance

NYSE ELMD opened at $29.20 on Wednesday. The stock has a market capitalization of $247.03 million, a P/E ratio of 40.56 and a beta of 0.33. The firm’s 50-day moving average is $31.13 and its two-hundred day moving average is $24.45. Electromed, Inc. has a 12 month low of $10.05 and a 12 month high of $35.56.

Electromed (NYSE:ELMD) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.03 by $0.13. Electromed had a net margin of 11.34% and a return on equity of 15.32%. The firm had revenue of $14.67 million for the quarter.

Electromed Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.